logo
Select company
Select metric
$ 196.21MNet Cash Flow - Financing
VS
Market
12
Sector
7
Industry
10
History
18
$ 14.77Close
$ 7 - $ 26.84 52-Week Range
Ticker Information

Ticker

XNCR

Company Name

XENCOR INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XENCOR INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XNCR - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 196.21M
3/31/2025$ 196.61M
12/31/2024$ 197.15M
9/30/2024$ 209.97M
6/30/2024$ 22.58M
3/31/2024$ 25.45M
12/31/2023$ 26.18M
9/30/2023$ 4.37M
6/30/2023$ 5.3M
3/31/2023$ 5.89M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XENCOR INC's latest trailing twelve months (TTM) CF - Financing stands at $ 11.43M.
  • Over the past 5 years, XENCOR INC's average CF - Financing has been $ 57.21M.
  • The median CF - Financing for XENCOR INC during this period was $ 24.01M
  • XENCOR INC reached its highest CF - Financing over the past 5 years at $ 209.97M.
  • The lowest CF - Financing recorded by XENCOR INC in the same timeframe $ 4.37M

XENCOR INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
RGNX : REGENXBIO INC $ 114.84MANAB : ANAPTYSBIO INC $ 19.71MCTMX : CYTOMX THERAPEUTICS INC $ 95.8MKURA : KURA ONCOLOGY INC $ 3.67MPHAT : PHATHOM PHARMACEUTICALS INC $ 148.18MMRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ -241.81MSAGE : SAGE THERAPEUTICS INC $ 1.12MGYRE : GYRE THERAPEUTICS INC $ 24.98MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ 1.3MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ 202.69M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

XNCR - Net Cash Flow - Financing, Last 5 years

$ 4.37M

Minimum

Sep 30, 2023

$ 209.97M

Maximum

Sep 30, 2024

$ 57.21M

Average

$ 24.01M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.74M with a standard deviation of $ 119.11M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -367.1M
max$ 366M
average$ -6.74M
median$ 314K
std$ 119.11M